Standout Papers

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets 2023 2026 202471
  1. The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets (2023)
    Kimberley El, Jonathan D. Douros et al. Nature Metabolism

Immediate Impact

1 from Science/Nature 67 standout
Sub-graph 1 of 22

Citing Papers

Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
2 intermediate papers

Works of Kimberley El being referenced

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets
2023 Standout
The role of GIP in α-cells and glucagon secretion
2019

Author Peers

Author Last Decade Papers Cites
Kimberley El 236 288 215 12 466
Jelena Kolic 278 203 322 13 531
Takanari Harada 222 305 206 12 540
Zhibo An 278 284 199 14 561
M. Dodson Michael 288 280 204 19 572
Roxane Lussier 345 163 215 14 548
Jeanette Teague 265 140 263 12 449
Elizabeth A. Killion 133 214 240 15 511
Susanna Mac 191 395 247 9 557
Johanne H. Ellenbroek 277 251 200 12 556
Dianne Matthews 180 266 130 14 496

All Works

Loading papers...

Rankless by CCL
2026